Cleveland Clinic Abu Dhabi adopts $50K-plus neurovascular device to treat complex aneurysms

Cleveland Clinic Abu Dhabi adopted a specialized neurovascular device on October 1, 2024, for complex brain aneurysm repair. The hospital is the first facility in the Middle East to use this technology for intracranial procedures. The device increases precision during endovascular coiling and stent placement.

The Department of Health Abu Dhabi (DOH) requires the hospital to decrease patient reliance on overseas referrals. Surgical teams at Cleveland Clinic Abu Dhabi expect the technology to reduce operative times compared to traditional flow-diversion methods. The neurology department manages 300 neurovascular cases each year.

Executive leadership purchased the device to comply with the DOH mandate for higher complexity care within the emirate. Chief Financial Officer Omar Al Naqbi tracks reduced recovery times and lower readmission rates as primary financial metrics. The medical team will publish outcome data in October 2025 to determine if the treatment model is scalable for other regional facilities.

Other UAE hospitals should evaluate their neurosurgical toolkits against these clinical standards. If Cleveland Clinic Abu Dhabi data shows a decrease in neurological deficits, the DOH may update clinical guidelines for interventional neuroradiology. Competitors monitor these procedures to refine technology procurement for the 2026 fiscal year.